Nava Therapeutics

Precision lipid nanoparticles for next-generation RNA therapeutics

Nava Therapeutics is developing genetic medicines using a modular platform of novel lipid nanoparticles. Its LNPs are engineered to deliver RNA safely and selectively to organs and cell types that remain difficult to reach with current delivery systems.

Origin

United States

Investment year

2024

Status

Current

Industries

Deeptech

Business model

Hardware